Kymera Therapeutics (KYMR) Other Non-Current Liabilities (2020 - 2023)
Kymera Therapeutics (KYMR) reported Other Non-Current Liabilities of $8,000 for Q3 2023, down 96.9% from $256,000 a year earlier and down 96.5% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Other Non-Current Liabilities (2020 - 2023) Analysis & Trends
At the end of FY2022, Kymera Therapeutics posted Other Non-Current Liabilities of $248,000, up 275.8% from FY2021.
- By year, Other Non-Current Liabilities came in at $66,000 in FY2021 (-34.0%) and $100,000 in FY2020.
- The Q3 2023 figure ranks as the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2020.
- Year over year, Other Non-Current Liabilities has now declined in each of the last three quarters, with growth averaging 95.8% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2022 (growth of 275.8%); the low point was Q3 2023 (a decline of 96.9%).
- Per Business Quant data, the three quarters before Q3 2023 came in at $230,000 (Q2 2023), $237,000 (Q1 2023) and $248,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | 237,000.00 |
| Dec 31, 2022 | 248,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 264,000.00 |
| Mar 31, 2022 | 273,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 84,000.00 |
| Mar 31, 2021 | 92,000.00 |
| Dec 31, 2020 | 100,000.00 |
API Access
Kymera Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();